{"id":28011,"date":"2022-07-13T19:55:00","date_gmt":"2022-07-13T11:55:00","guid":{"rendered":"https:\/\/flcube.com\/?p=28011"},"modified":"2025-02-25T19:58:29","modified_gmt":"2025-02-25T11:58:29","slug":"chinas-7th-vbp-round-yields-65-5-drug-price-cuts-foreign-firms-secure-bids","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=28011","title":{"rendered":"China&#8217;s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids"},"content":{"rendered":"\n<p>China&#8217;s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price reduction compared to ceiling prices, as domestic firms dominated the tender. The results, announced by the national alliance procurement office, are open for public feedback until July 15, with full province-by-province allocations pending.<\/p>\n\n\n\n<p><strong>Key Results<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Scale<\/strong>: 60 drug products, 163 companies, 327 tender spots.<\/li>\n\n\n\n<li><strong>Price Cuts<\/strong>: Average 65.5% reduction in winning bids.<\/li>\n\n\n\n<li><strong>Withdrawals<\/strong>: Sulfamethoxazole (oral normal release) withdrawn from the original 61-product list.<\/li>\n<\/ul>\n\n\n\n<p><strong>Domestic Companies Dominate<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Qilu Pharma<\/strong>: Secured 16 tender spots.<\/li>\n\n\n\n<li><strong>Yangtze River Pharma<\/strong>: 12 wins.<\/li>\n\n\n\n<li><strong>Kelun Pharma<\/strong>: 11 wins.<\/li>\n\n\n\n<li><strong>Sinopharm<\/strong>: 10 wins.<\/li>\n\n\n\n<li><strong>CSPC Group<\/strong>: 9 wins.<\/li>\n\n\n\n<li><strong>Sino Bio<\/strong>: 9 wins.<\/li>\n\n\n\n<li><strong>CR Double-Crane<\/strong>: 6 wins.<\/li>\n<\/ul>\n\n\n\n<p><strong>Foreign Firms Secure Bids<\/strong><br>Six foreign companies won bids:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hetero (India)<\/strong>: Oseltamivir (3rd-lowest bid).<\/li>\n\n\n\n<li><strong>Bracco (Italy)<\/strong>: Iopamidol (contrast agent, 2nd-lowest bid).<\/li>\n\n\n\n<li><strong>Almirall SA (Spain)<\/strong>: Ebastine (antihistamine).<\/li>\n\n\n\n<li><strong>Sandoz<\/strong>: Ezetimibe (cholesterol-lowering).<\/li>\n\n\n\n<li><strong>Astellas<\/strong>: Micafungin (anti-fungal).<\/li>\n\n\n\n<li><strong>Pfizer<\/strong>: Tigecycline (antibiotic).<\/li>\n<\/ul>\n\n\n\n<p>Notably, iopamidol, ebastine, and tigecycline were won by originator companies, a shift from recent trends.<\/p>\n\n\n\n<p><strong>Financial Impact<\/strong><br>The VBP tender is projected to save China RMB18.5 billion ($2.75 billion) annually in health expenditure. New drug prices will take effect from November 2022.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[67,82],"class_list":["post-28011","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nhsa-prev-smia","tag-vbp-voluem-based-procurement"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China&#039;s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price reduction compared to ceiling prices, as domestic firms dominated the tender. The results, announced by the national alliance procurement office, are open for public feedback until July 15, with full province-by-province allocations pending.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=28011\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China&#039;s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=28011\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-13T11:55:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-25T11:58:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28011#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28011\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China&#8217;s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids\",\"datePublished\":\"2022-07-13T11:55:00+00:00\",\"dateModified\":\"2025-02-25T11:58:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28011\"},\"wordCount\":191,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NHSA (prev. SMIA)\",\"VBP (voluem-based procurement)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28011#respond\"]}],\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28011\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=28011\",\"name\":\"China's 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2022-07-13T11:55:00+00:00\",\"dateModified\":\"2025-02-25T11:58:29+00:00\",\"description\":\"China's 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price reduction compared to ceiling prices, as domestic firms dominated the tender. The results, announced by the national alliance procurement office, are open for public feedback until July 15, with full province-by-province allocations pending.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28011#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28011\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28011#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China&#8217;s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids - Insight, China&#039;s Pharmaceutical Industry","description":"China's 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price reduction compared to ceiling prices, as domestic firms dominated the tender. The results, announced by the national alliance procurement office, are open for public feedback until July 15, with full province-by-province allocations pending.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=28011","og_locale":"en_US","og_type":"article","og_title":"China's 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=28011","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2022-07-13T11:55:00+00:00","article_modified_time":"2025-02-25T11:58:29+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=28011#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=28011"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China&#8217;s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids","datePublished":"2022-07-13T11:55:00+00:00","dateModified":"2025-02-25T11:58:29+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=28011"},"wordCount":191,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NHSA (prev. SMIA)","VBP (voluem-based procurement)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=28011#respond"]}],"copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=28011","url":"https:\/\/flcube.com\/?p=28011","name":"China's 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2022-07-13T11:55:00+00:00","dateModified":"2025-02-25T11:58:29+00:00","description":"China's 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price reduction compared to ceiling prices, as domestic firms dominated the tender. The results, announced by the national alliance procurement office, are open for public feedback until July 15, with full province-by-province allocations pending.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=28011#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=28011"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=28011#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China&#8217;s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28011"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28011\/revisions"}],"predecessor-version":[{"id":28012,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28011\/revisions\/28012"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}